Maintain Respiratory Muscle Function and Reduce Pneumonia Risk in Cancer Patients
| Status: | Enrolling by invitation |
|---|---|
| Conditions: | Cancer, Cancer, Pneumonia |
| Therapuetic Areas: | Oncology, Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 8/18/2018 |
| Start Date: | May 25, 2018 |
| End Date: | May 2, 2020 |
Resistance Training and 1,25 (OH)2D3 Administration to Maintain Respiratory Muscle Function and Reduce Pneumonia Risk in Cancer Patients
This research is intended to begin to explore the impact of inspiratory muscle resistance
exercise and/or 1,25(OH)2D3 for improving respiratory muscle strength in cancer patients
(subjects).
exercise and/or 1,25(OH)2D3 for improving respiratory muscle strength in cancer patients
(subjects).
Inclusion Criteria:
- Diagnosis of cancer
- Renal and hepatic function (creatinine normal; bilirubin
- No contraindication to receive either of the planned interventions of inspiratory
resistance training or 1,25(OH)2D3 in the opinion of the healthcare provider
- No difficulties with swallowing oral medications in the opinion of the enrolling
physician
Exclusion Criteria:
- Patient is taking calcium or Vitamin D supplements and is unwilling to stop for 8
weeks
- Severe chronic obstructive pulmonary disease (oxygen dependent or patient self-reports
unable to walk one block without difficulty)
- Calcium or phosphorus level above the institutional upper limit of normal
We found this trial at
1
site
Mayo Clinic Rochester Mayo Clinic is a nonprofit worldwide leader in medical care, research and...
Click here to add this to my saved trials
